Atlas Trials

Meningeal Hemangiopericytoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Meningeal Hemangiopericytoma

RecordFirmDate
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926)City of Hope Medical Center2010-05-01

Track Meningeal Hemangiopericytoma automatically

Every clearance here is in the API, with alerts when new ones post.